{"id": "IEPA.d2.s2_IEPA.d2.s2.p0", "text": "SP ewes also had greater incorporation of [3H]inositol into inositol trisphosphate (IP3) (+3449%, p less than 0.01) and total inositol phosphate (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "text_with_entity_marker": "SP ewes also had greater incorporation of [3H]inositol into [E1]inositol trisphosphate[/E1] (IP3) (+3449%, p less than 0.01) and total [E2]inositol phosphate[/E2] (IP) (+760%, p less than 0.08), in response to oxytocin, than did oCSP ewes (+553 and +168% for IP3 and total IP, respectively) in endometrium collected at ovariectomy/hysterectomy on Day 16", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "inositol trisphosphate", "entity_1_idx": [[60, 82]], "entity_1_idx_in_text_with_entity_marker": [64, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol phosphate", "entity_2_idx": [[126, 144]], "entity_2_idx_in_text_with_entity_marker": [139, 157], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d9.s19_IEPA.d9.s19.p0", "text": "Administration of OT (1 microM) for 15 sec increased inositol 1,4,5-trisphosphate (IP3) formation by 61%", "text_with_entity_marker": "Administration of [E1]OT[/E1] (1 microM) for 15 sec increased [E2]inositol 1,4,5-trisphosphate[/E2] (IP3) formation by 61%", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[18, 20]], "entity_1_idx_in_text_with_entity_marker": [22, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol 1,4,5-trisphosphate", "entity_2_idx": [[53, 81]], "entity_2_idx_in_text_with_entity_marker": [66, 94], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d12.s29_IEPA.d12.s29.p0", "text": "These results suggest that APP-S secretion and A beta production in NT2N neurons are regulated by the muscarinic/phospholipase C signal transduction pathway", "text_with_entity_marker": "These results suggest that [E1]APP-S[/E1] secretion and [E2]A beta[/E2] production in NT2N neurons are regulated by the muscarinic/phospholipase C signal transduction pathway", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "APP-S", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "A beta", "entity_2_idx": [[47, 53]], "entity_2_idx_in_text_with_entity_marker": [60, 66], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d17.s34_IEPA.d17.s34.p1", "text": "The aim of this study was to investigate the effects of hCG, hCG plus oxytocin and oxytocin on [3H] inositol phosphate (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts", "text_with_entity_marker": "The aim of this study was to investigate the effects of hCG, hCG plus [E1]oxytocin[/E1] and oxytocin on [3H] [E2]inositol phosphate[/E2] (IP) formations in porcine myometrial cells obtained from ovariectomized and cyclic gilts", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[70, 78]], "entity_1_idx_in_text_with_entity_marker": [74, 82], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol phosphate", "entity_2_idx": [[100, 118]], "entity_2_idx_in_text_with_entity_marker": [113, 131], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d18.s40_IEPA.d18.s40.p0", "text": "The relative risks between highest and lowest quarters of flavonoid intake adjusted for age, smoking, serum cholesterol concentration, blood pressure, and body mass index were 0.69 (95% confidence interval 0.53 to 0.90) and 0.54 (0.33 to 0.87) for total and coronary mortality, respectively", "text_with_entity_marker": "The relative risks between highest and lowest quarters of [E1]flavonoid[/E1] intake adjusted for age, smoking, serum [E2]cholesterol[/E2] concentration, blood pressure, and body mass index were 0.69 (95% confidence interval 0.53 to 0.90) and 0.54 (0.33 to 0.87) for total and coronary mortality, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "flavonoid", "entity_1_idx": [[58, 67]], "entity_1_idx_in_text_with_entity_marker": [62, 71], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "cholesterol", "entity_2_idx": [[108, 119]], "entity_2_idx_in_text_with_entity_marker": [121, 132], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d23.s47_IEPA.d23.s47.p3", "text": "The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized PrPc, transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a prion protein-specific protein kinase.", "text_with_entity_marker": "The resulting abnormally phosphorylated PrPsc aggregates to freshly synthesized [E1]PrPc[/E1], transforming it into same; due to a system of positive feedback invoked by the organophosphate-induced blockage of a [E2]prion protein[/E2]-specific protein kinase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PrPc", "entity_1_idx": [[80, 84]], "entity_1_idx_in_text_with_entity_marker": [84, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "prion protein", "entity_2_idx": [[203, 216]], "entity_2_idx_in_text_with_entity_marker": [216, 229], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s51_IEPA.d24.s51.p2", "text": "The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate", "text_with_entity_marker": "The [E1]oxytocin[/E1] antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced [E2]insulin[/E2] secretion was difficult to evaluate", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[4, 12]], "entity_1_idx_in_text_with_entity_marker": [8, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[163, 170]], "entity_2_idx_in_text_with_entity_marker": [176, 183], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s52_IEPA.d24.s52.p0", "text": "Intracerebroventricular injections of 200 ng oxytocin caused a significant rise not only of insulin but also of glucagon and glucose levels", "text_with_entity_marker": "Intracerebroventricular injections of 200 ng [E1]oxytocin[/E1] caused a significant rise not only of [E2]insulin[/E2] but also of glucagon and glucose levels", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[45, 53]], "entity_1_idx_in_text_with_entity_marker": [49, 57], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[92, 99]], "entity_2_idx_in_text_with_entity_marker": [105, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s53_IEPA.d24.s53.p0", "text": "In contrast, nanogram amounts of oxytocin administered ICV cause a rise of insulin levels", "text_with_entity_marker": "In contrast, nanogram amounts of [E1]oxytocin[/E1] administered ICV cause a rise of [E2]insulin[/E2] levels", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[75, 82]], "entity_2_idx_in_text_with_entity_marker": [88, 95], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d30.s62_IEPA.d30.s62.p0", "text": "The influence of myrigalone B, a flavonoid from the fruit exudate of Myrica gale L. on Cu(2+)-induced oxidation of low density lipoprotein from cholesterol fed rabbits was investigated", "text_with_entity_marker": "The influence of myrigalone B, a [E1]flavonoid[/E1] from the fruit exudate of Myrica gale L. on Cu(2+)-induced oxidation of low density lipoprotein from [E2]cholesterol[/E2] fed rabbits was investigated", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "flavonoid", "entity_1_idx": [[33, 42]], "entity_1_idx_in_text_with_entity_marker": [37, 46], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "cholesterol", "entity_2_idx": [[144, 155]], "entity_2_idx_in_text_with_entity_marker": [157, 168], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d31.s65_IEPA.d31.s65.p0", "text": "These results indicate that OT induces endometrial IP3 production in a rapid manner indicative of a second-messenger system", "text_with_entity_marker": "These results indicate that [E1]OT[/E1] induces endometrial [E2]IP3[/E2] production in a rapid manner indicative of a second-messenger system", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[28, 30]], "entity_1_idx_in_text_with_entity_marker": [32, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[51, 54]], "entity_2_idx_in_text_with_entity_marker": [64, 67], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s77_IEPA.d33.s77.p0", "text": "When the ovariectomized pregnant rabbits were treated with estrogen, OT receptors in the myometrium were induced, and OT acquired the ability to stimulate IP3 formation", "text_with_entity_marker": "When the ovariectomized pregnant rabbits were treated with estrogen, OT receptors in the myometrium were induced, and [E1]OT[/E1] acquired the ability to stimulate [E2]IP3[/E2] formation", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[118, 120]], "entity_1_idx_in_text_with_entity_marker": [122, 124], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[155, 158]], "entity_2_idx_in_text_with_entity_marker": [168, 171], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d34.s82_IEPA.d34.s82.p0", "text": "In brown adipose tissue of lean animals, multilocular uncoupling protein (UCP)-positive brown adipocytes had typical brown mitochondria and were leptin-negative, both in fed and fasted conditions", "text_with_entity_marker": "In brown adipose tissue of lean animals, multilocular [E1]uncoupling protein[/E1] (UCP)-positive brown adipocytes had typical brown mitochondria and were [E2]leptin[/E2]-negative, both in fed and fasted conditions", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "uncoupling protein", "entity_1_idx": [[54, 72]], "entity_1_idx_in_text_with_entity_marker": [58, 76], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[145, 151]], "entity_2_idx_in_text_with_entity_marker": [158, 164], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d36.s88_IEPA.d36.s88.p2", "text": "The present studies compared the effects of insulin in rat adipocytes with the effects of oxytocin and peroxovanadate, which mimic some effects of insulin", "text_with_entity_marker": "The present studies compared the effects of insulin in rat adipocytes with the effects of [E1]oxytocin[/E1] and peroxovanadate, which mimic some effects of [E2]insulin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "oxytocin", "entity_1_idx": [[90, 98]], "entity_1_idx_in_text_with_entity_marker": [94, 102], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[147, 154]], "entity_2_idx_in_text_with_entity_marker": [160, 167], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d40.s97_IEPA.d40.s97.p0", "text": "There was a 98% greater augmentation of insulin secretion by 16.7 mM glucose (in the presence of diazoxide and 40 mM K+) in primed islets; however, the ability of high glucose to augment PLC activity bore no relationship to the secretory response", "text_with_entity_marker": "There was a 98% greater augmentation of [E1]insulin[/E1] secretion by 16.7 mM glucose (in the presence of diazoxide and 40 mM K+) in primed islets; however, the ability of high glucose to augment [E2]PLC[/E2] activity bore no relationship to the secretory response", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[40, 47]], "entity_1_idx_in_text_with_entity_marker": [44, 51], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[187, 190]], "entity_2_idx_in_text_with_entity_marker": [200, 203], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d41.s101_IEPA.d41.s101.p0", "text": "The further addition of carbachol, an agonist that activates an isozyme of phospholipase C distinct from that activated by glucose, together with K+, 20 mM glucose, plus diazoxide resulted in a sustained amplification of insulin secretion from mouse but not rat islets", "text_with_entity_marker": "The further addition of carbachol, an agonist that activates an isozyme of [E1]phospholipase C[/E1] distinct from that activated by glucose, together with K+, 20 mM glucose, plus diazoxide resulted in a sustained amplification of [E2]insulin[/E2] secretion from mouse but not rat islets", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[75, 90]], "entity_1_idx_in_text_with_entity_marker": [79, 94], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[221, 228]], "entity_2_idx_in_text_with_entity_marker": [234, 241], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d43.s109_IEPA.d43.s109.p0", "text": "Here we show that leptin alters in pancreatic islets the mRNA of the genes encoding enzymes of free fatty acid metabolism and uncoupling protein-2 (UCP-2)", "text_with_entity_marker": "Here we show that [E1]leptin[/E1] alters in pancreatic islets the mRNA of the genes encoding enzymes of free fatty acid metabolism and [E2]uncoupling protein-2[/E2] (UCP-2)", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-2", "entity_2_idx": [[126, 146]], "entity_2_idx_in_text_with_entity_marker": [139, 159], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d46.s117_IEPA.d46.s117.p0", "text": "It is possible that this phospholipase C stimulation by amyloid beta protein is a receptor-mediated process", "text_with_entity_marker": "It is possible that this [E1]phospholipase C[/E1] stimulation by [E2]amyloid[/E2] beta protein is a receptor-mediated process", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[25, 40]], "entity_1_idx_in_text_with_entity_marker": [29, 44], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "amyloid", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d48.s125_IEPA.d48.s125.p0", "text": "These data demonstrate a leptin-induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which leptin increases energy expenditure is through increased thermogenesis in BAT, including increased expression of UCP", "text_with_entity_marker": "These data demonstrate a [E1]leptin[/E1]-induced increase in energy expenditure in nonmutant rodents and suggest that one mechanism by which [E2]leptin[/E2] increases energy expenditure is through increased thermogenesis in BAT, including increased expression of UCP", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[25, 31]], "entity_1_idx_in_text_with_entity_marker": [29, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[132, 138]], "entity_2_idx_in_text_with_entity_marker": [145, 151], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d50.s127_IEPA.d50.s127.p0", "text": "Insulin secretion is regulated by changes in blood glucose, as well as by peptides from the gastrointestinal tract and neurotransmitters that activate the pancreatic islet adenylyl cyclase (e.g., glucagon-like peptide-1) and phospholipase C (PLC) (e.g., acetylcholine) signaling pathways to further potentiate glucose-induced insulin secretion", "text_with_entity_marker": "[E1]Insulin[/E1] secretion is regulated by changes in blood glucose, as well as by peptides from the gastrointestinal tract and neurotransmitters that activate the pancreatic islet adenylyl cyclase (e.g., glucagon-like peptide-1) and [E2]phospholipase C[/E2] (PLC) (e.g., acetylcholine) signaling pathways to further potentiate glucose-induced insulin secretion", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Insulin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[225, 240]], "entity_2_idx_in_text_with_entity_marker": [238, 253], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d50.s131_IEPA.d50.s131.p0", "text": "Leptin was equally effective in constraining the enhanced insulin release from islets of ob/ob mice caused by protein kinase C (PKC) activation, a downstream mediator of the PLC signal pathway", "text_with_entity_marker": "Leptin was equally effective in constraining the enhanced [E1]insulin[/E1] release from islets of ob/ob mice caused by protein kinase C (PKC) activation, a downstream mediator of the [E2]PLC[/E2] signal pathway", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[174, 177]], "entity_2_idx_in_text_with_entity_marker": [187, 190], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d53.s137_IEPA.d53.s137.p2", "text": "During luteinization of bovine granulosa cells in vitro in the presence of insulin, or insulin plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone oxytocin, with secretion of the peptide into the medium", "text_with_entity_marker": "During luteinization of bovine granulosa cells in vitro in the presence of insulin, or [E1]insulin[/E1] plus forskolin, there is a massive upregulation not only of progesterone production, but also of the gene for the peptide hormone [E2]oxytocin[/E2], with secretion of the peptide into the medium", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[87, 94]], "entity_1_idx_in_text_with_entity_marker": [91, 98], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[225, 233]], "entity_2_idx_in_text_with_entity_marker": [238, 246], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d55.s142_IEPA.d55.s142.p0", "text": "These results support the hypothesis that the heart may be a target organ for AVP and that AVP modulates IL-1beta-induced iNOS expression in myocytes through the V1a receptor, which is mediated at least partially via activation of protein kinase C", "text_with_entity_marker": "These results support the hypothesis that the heart may be a target organ for [E1]AVP[/E1] and that [E2]AVP[/E2] modulates IL-1beta-induced iNOS expression in myocytes through the V1a receptor, which is mediated at least partially via activation of protein kinase C", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[78, 81]], "entity_1_idx_in_text_with_entity_marker": [82, 85], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[91, 94]], "entity_2_idx_in_text_with_entity_marker": [104, 107], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d58.s150_IEPA.d58.s150.p0", "text": "We have recently shown that AVP causes a protein kinase C (PKC)-dependent increase in ACTH release and biosynthesis in ovine anterior pituitary cells", "text_with_entity_marker": "We have recently shown that [E1]AVP[/E1] causes a [E2]protein kinase C[/E2] (PKC)-dependent increase in ACTH release and biosynthesis in ovine anterior pituitary cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[41, 57]], "entity_2_idx_in_text_with_entity_marker": [54, 70], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d58.s153_IEPA.d58.s153.p0", "text": "We conclude that: (1) AVP causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the AVP-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.", "text_with_entity_marker": "We conclude that: (1) [E1]AVP[/E1] causes a rapid, and reversible, phosphorylation of the MARCKS protein in the ovine anterior pituitary; (2) since the [E2]AVP[/E2]-induced increase in MARCKS phosphorylation occurs much earlier in these cells than does PKC trans-location, MARCKS phosphorylation may provide a more sensitive index of the onset of PKC activation than the translocation assay; (3) the close temporal association between MARCKS phosphorylation and the rapid early release of ACTH suggests that MARCKS phosphorylation may be involved in the initial intracellular events that underly exocytosis of the hormone.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "AVP", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[143, 146]], "entity_2_idx_in_text_with_entity_marker": [156, 159], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d61.s157_IEPA.d61.s157.p0", "text": "Secreted form of beta-amyloid precursor protein activates protein kinase C and phospholipase Cgamma1 in cultured embryonic rat neocortical cells", "text_with_entity_marker": "Secreted form of [E1]beta-amyloid[/E1] precursor protein activates protein kinase C and [E2]phospholipase Cgamma1[/E2] in cultured embryonic rat neocortical cells", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-amyloid", "entity_1_idx": [[17, 29]], "entity_1_idx_in_text_with_entity_marker": [21, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cgamma1", "entity_2_idx": [[79, 100]], "entity_2_idx_in_text_with_entity_marker": [92, 113], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d66.s166_IEPA.d66.s166.p2", "text": "However, the AVP-dependent stimulation required activation of protein kinase C (PKC), whereas the inhibition was PKC independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct", "text_with_entity_marker": "However, the AVP-dependent stimulation required activation of [E1]protein kinase C[/E1] (PKC), whereas the inhibition was [E2]PKC[/E2] independent, indicating that the NGF-induced signaling pathways leading to inhibition and stimulation of HCO3- absorption are distinct", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein kinase C", "entity_1_idx": [[62, 78]], "entity_1_idx_in_text_with_entity_marker": [66, 82], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[113, 116]], "entity_2_idx_in_text_with_entity_marker": [126, 129], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s168_IEPA.d67.s168.p1", "text": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "text_with_entity_marker": "To determine the functional significance of the interaction of [E1]PLCgamma[/E1] and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from [E2]PLCgamma[/E2] to block insulin-stimulated GLUT4 translocation", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLCgamma", "entity_1_idx": [[63, 71]], "entity_1_idx_in_text_with_entity_marker": [67, 75], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCgamma", "entity_2_idx": [[216, 224]], "entity_2_idx_in_text_with_entity_marker": [229, 237], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s168_IEPA.d67.s168.p3", "text": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "text_with_entity_marker": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of [E1]PLC[/E1], U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from [E2]PLCgamma[/E2] to block insulin-stimulated GLUT4 translocation", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PLC", "entity_1_idx": [[116, 119]], "entity_1_idx_in_text_with_entity_marker": [120, 123], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCgamma", "entity_2_idx": [[216, 224]], "entity_2_idx_in_text_with_entity_marker": [229, 237], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d70.s171_IEPA.d70.s171.p0", "text": "Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and OT and the OT response to insulin-induced hypoglycemia", "text_with_entity_marker": "Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and [E1]OT[/E1] and the [E2]OT[/E2] response to insulin-induced hypoglycemia", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "OT", "entity_1_idx": [[118, 120]], "entity_1_idx_in_text_with_entity_marker": [122, 124], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[129, 131]], "entity_2_idx_in_text_with_entity_marker": [142, 144], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d70.s171_IEPA.d70.s171.p2", "text": "Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and OT and the OT response to insulin-induced hypoglycemia", "text_with_entity_marker": "Inhibition of 5-HT3 serotonergic receptors with ondansetron (4 or 8 mg) did not modify the basal secretion of AVP and OT and the [E1]OT[/E1] response to [E2]insulin[/E2]-induced hypoglycemia", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[129, 131]], "entity_1_idx_in_text_with_entity_marker": [133, 135], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[144, 151]], "entity_2_idx_in_text_with_entity_marker": [157, 164], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d71.s172_IEPA.d71.s172.p0", "text": "HvSPY coexpression largely abolished GA3-induced activity of an alpha-amylase promoter.", "text_with_entity_marker": "HvSPY coexpression largely abolished [E1]GA3[/E1]-induced activity of an [E2]alpha-amylase[/E2] promoter.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "GA3", "entity_1_idx": [[37, 40]], "entity_1_idx_in_text_with_entity_marker": [41, 44], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d79.s189_IEPA.d79.s189.p0", "text": "OT evokes the release of Ca2+ from IP3-sensitive intracellular stores", "text_with_entity_marker": "[E1]OT[/E1] evokes the release of Ca2+ from [E2]IP3[/E2]-sensitive intracellular stores", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "OT", "entity_1_idx": [[0, 2]], "entity_1_idx_in_text_with_entity_marker": [4, 6], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[35, 38]], "entity_2_idx_in_text_with_entity_marker": [48, 51], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d80.s192_IEPA.d80.s192.p0", "text": "Co-injection of SHU9119 also inhibited completely the leptin-induced increase in UCP-1 mRNA expression in the BAT", "text_with_entity_marker": "Co-injection of SHU9119 also inhibited completely the [E1]leptin[/E1]-induced increase in [E2]UCP-1[/E2] mRNA expression in the BAT", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[54, 60]], "entity_1_idx_in_text_with_entity_marker": [58, 64], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-1", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d83.s198_IEPA.d83.s198.p0", "text": "Furthermore, immunocytochemical studies showed the A beta-induced neuronal MAC expression on the SH-SY5Y cells after CD59 was removed by PIPLC or blocked by anti-CD59 antibody", "text_with_entity_marker": "Furthermore, immunocytochemical studies showed the [E1]A beta[/E1]-induced neuronal MAC expression on the SH-SY5Y cells after CD59 was removed by [E2]PIPLC[/E2] or blocked by anti-CD59 antibody", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A beta", "entity_1_idx": [[51, 57]], "entity_1_idx_in_text_with_entity_marker": [55, 61], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PIPLC", "entity_2_idx": [[137, 142]], "entity_2_idx_in_text_with_entity_marker": [150, 155], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p2", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of [E1]UCP3[/E1] and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding [E2]UCP3[/E2] and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP3", "entity_1_idx": [[50, 54]], "entity_1_idx_in_text_with_entity_marker": [54, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[364, 368]], "entity_2_idx_in_text_with_entity_marker": [377, 381], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d88.s207_IEPA.d88.s207.p5", "text": "To elucidate the pathophysiologic significance of UCP3 and UCP2 in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding UCP3 and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "text_with_entity_marker": "To elucidate the pathophysiologic significance of UCP3 and [E1]UCP2[/E1] in the effect of TZDs on glucose metabolism and energy expenditure, we examined their basal mRNA levels in the WAT, brown adipose tissue (BAT), and skeletal muscle from Wistar fatty rats, a rat model of NIDDM and obesity with leptin receptor defect, and investigated expression of the genes encoding [E2]UCP3[/E2] and UCP2 in Wistar fatty rats and in Wistar lean rats with 2-week oral administration of 3 mg x kg(-1) x day(-1) pioglitazone, a TZD derivative", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[59, 63]], "entity_1_idx_in_text_with_entity_marker": [63, 67], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[364, 368]], "entity_2_idx_in_text_with_entity_marker": [377, 381], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d90.s214_IEPA.d90.s214.p0", "text": "The regulation of alpha-Amy2 genes by GA therefore involves an interplay of at least three different types of transcription factor", "text_with_entity_marker": "The regulation of [E1]alpha-Amy2[/E1] genes by [E2]GA[/E2] therefore involves an interplay of at least three different types of transcription factor", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-Amy2", "entity_1_idx": [[18, 28]], "entity_1_idx_in_text_with_entity_marker": [22, 32], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA", "entity_2_idx": [[38, 40]], "entity_2_idx_in_text_with_entity_marker": [51, 53], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s223_IEPA.d91.s223.p0", "text": "U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "text_with_entity_marker": "U-73122 at 8 mumol.L-1 totally abolished the [E1]Oxy[/E1]-induced increases in [Ca2+]i and IP3; however it reduced the [E2]Oxy[/E2]-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Oxy", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Oxy", "entity_2_idx": [[110, 113]], "entity_2_idx_in_text_with_entity_marker": [123, 126], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s223_IEPA.d91.s223.p1", "text": "U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "text_with_entity_marker": "U-73122 at 8 mumol.L-1 totally abolished the [E1]Oxy[/E1]-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in [E2]insulin[/E2] release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Oxy", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[134, 141]], "entity_2_idx_in_text_with_entity_marker": [147, 154], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s231_IEPA.d96.s231.p1", "text": "Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment", "text_with_entity_marker": "Downregulation of [E1]uncoupling protein 2[/E1] mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of [E2]leptin[/E2] treatment", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "uncoupling protein 2", "entity_1_idx": [[18, 38]], "entity_1_idx_in_text_with_entity_marker": [22, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s232_IEPA.d96.s232.p1", "text": "Leptin by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in UCP-2 mRNA in WAT (47-52%) and UCP-3 mRNA in SM (33-37%)", "text_with_entity_marker": "[E1]Leptin[/E1] by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in UCP-2 mRNA in WAT (47-52%) and [E2]UCP-3[/E2] mRNA in SM (33-37%)", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d99.s238_IEPA.d99.s238.p0", "text": "To study the effects of enhanced phosphoinositide hydrolysis on insulin secretion, phosphoinositide-specific phospholipase Cbeta1 (PLCbeta1) or PLCdelta1 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "text_with_entity_marker": "To study the effects of enhanced phosphoinositide hydrolysis on [E1]insulin[/E1] secretion, phosphoinositide-specific [E2]phospholipase Cbeta1[/E2] (PLCbeta1) or PLCdelta1 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[64, 71]], "entity_1_idx_in_text_with_entity_marker": [68, 75], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cbeta1", "entity_2_idx": [[109, 129]], "entity_2_idx_in_text_with_entity_marker": [122, 142], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d103.s242_IEPA.d103.s242.p0", "text": "The bovine ovarian granulosa cell model is a primary culture system where under stimulation by insulin or IGF-I and LH the endogenous oxytocin gene is massively upregulated", "text_with_entity_marker": "The bovine ovarian granulosa cell model is a primary culture system where under stimulation by [E1]insulin[/E1] or IGF-I and LH the endogenous [E2]oxytocin[/E2] gene is massively upregulated", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[95, 102]], "entity_1_idx_in_text_with_entity_marker": [99, 106], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[134, 142]], "entity_2_idx_in_text_with_entity_marker": [147, 155], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s251_IEPA.d108.s251.p0", "text": "Long-term changes in gastrin, cholecystokinin and insulin in response to oxytocin treatment", "text_with_entity_marker": "Long-term changes in gastrin, cholecystokinin and [E1]insulin[/E1] in response to [E2]oxytocin[/E2] treatment", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[73, 81]], "entity_2_idx_in_text_with_entity_marker": [86, 94], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s259_IEPA.d109.s259.p0", "text": "Fasting significantly decreased BAT UCP-1 and UCP-3 mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of leptin to fasted rats", "text_with_entity_marker": "Fasting significantly decreased BAT [E1]UCP-1[/E1] and [E2]UCP-3[/E2] mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of leptin to fasted rats", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-1", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[46, 51]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d110.s266_IEPA.d110.s266.p2", "text": "Western blots demonstrated expression of PKCalpha, betaI, epsilon, delta, and zeta in H9c2 cells; PKC inhibitors (staurosporine or Ro 31-8220) or down-regulation of PKCalpha, betaI, epsilon, and delta by long-term (24 h) TPA treatment caused a partial blockade of the AVP-induced response, whereas the A23187-induced AA release was unaffected by down-regulation of these isoforms", "text_with_entity_marker": "Western blots demonstrated expression of PKCalpha, betaI, epsilon, delta, and zeta in H9c2 cells; PKC inhibitors (staurosporine or Ro 31-8220) or down-regulation of [E1]PKCalpha[/E1], betaI, epsilon, and delta by long-term (24 h) TPA treatment caused a partial blockade of the [E2]AVP[/E2]-induced response, whereas the A23187-induced AA release was unaffected by down-regulation of these isoforms", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PKCalpha", "entity_1_idx": [[165, 173]], "entity_1_idx_in_text_with_entity_marker": [169, 177], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[268, 271]], "entity_2_idx_in_text_with_entity_marker": [281, 284], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d110.s267_IEPA.d110.s267.p0", "text": "AVP- or TPA-induced activation and tyrosine phosphorylation of p42 MAPK were completely blocked by down-regulation of PKCalpha, betaI, epsilon, and delta, but still occurred, together with the cytosolic PLA2 mobility shift, in the absence of external Ca2+", "text_with_entity_marker": "[E1]AVP[/E1]- or TPA-induced activation and tyrosine phosphorylation of p42 MAPK were completely blocked by down-regulation of [E2]PKCalpha[/E2], betaI, epsilon, and delta, but still occurred, together with the cytosolic PLA2 mobility shift, in the absence of external Ca2+", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKCalpha", "entity_2_idx": [[118, 126]], "entity_2_idx_in_text_with_entity_marker": [131, 139], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d110.s268_IEPA.d110.s268.p0", "text": "These results show that AVP-induced AA release in H9c2 cells is secondary to activation of the V1 receptor/Gq protein/PLCP pathway, leading to an influx of extracellular Ca2+ and activation of PKCalpha, betaI, epsilon, and delta", "text_with_entity_marker": "These results show that [E1]AVP[/E1]-induced AA release in H9c2 cells is secondary to activation of the V1 receptor/Gq protein/PLCP pathway, leading to an influx of extracellular Ca2+ and activation of [E2]PKCalpha[/E2], betaI, epsilon, and delta", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKCalpha", "entity_2_idx": [[193, 201]], "entity_2_idx_in_text_with_entity_marker": [206, 214], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s278_IEPA.d115.s278.p0", "text": "It has been suggested that insulin secretion from pancreatic islets may be  mediated in part by activation of phospholipases C (PLCs) and  phosphoinositide hydrolysis.", "text_with_entity_marker": "It has been suggested that [E1]insulin[/E1] secretion from pancreatic islets may be  mediated in part by activation of [E2]phospholipases C[/E2] (PLCs) and  phosphoinositide hydrolysis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipases C", "entity_2_idx": [[110, 126]], "entity_2_idx_in_text_with_entity_marker": [123, 139], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s279_IEPA.d115.s279.p0", "text": "The purpose of this study was to determine  whether the relatively modest fuel-stimulated insulin secretion responses  of rodent beta-cell lines might be explained by inadequate expression or  activation of PLC isoforms.", "text_with_entity_marker": "The purpose of this study was to determine  whether the relatively modest fuel-stimulated [E1]insulin[/E1] secretion responses  of rodent beta-cell lines might be explained by inadequate expression or  activation of [E2]PLC[/E2] isoforms.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[90, 97]], "entity_1_idx_in_text_with_entity_marker": [94, 101], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[207, 210]], "entity_2_idx_in_text_with_entity_marker": [220, 223], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d117.s285_IEPA.d117.s285.p0", "text": "The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone", "text_with_entity_marker": "The second class of mutant, gse ([E1]GA[/E1] sensitivity), differed principally in [E2]GA[/E2] sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "GA", "entity_1_idx": [[33, 35]], "entity_1_idx_in_text_with_entity_marker": [37, 39], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA", "entity_2_idx": [[74, 76]], "entity_2_idx_in_text_with_entity_marker": [87, 89], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s292_IEPA.d122.s292.p0", "text": "To study if leptin also has direct peripherally mediated effects on these processes, this hormone (1 mg/day) or its vehicle was infused i.v. for 4 days to lean rats and insulin-stimulated glucose utilization in skeletal muscle and adipose tissue as well as the expression of UCP messenger RNAs (mRNAs) in brown adipose tissue were measured", "text_with_entity_marker": "To study if [E1]leptin[/E1] also has direct peripherally mediated effects on these processes, this hormone (1 mg/day) or its vehicle was infused i.v. for 4 days to lean rats and insulin-stimulated glucose utilization in skeletal muscle and adipose tissue as well as the expression of [E2]UCP[/E2] messenger RNAs (mRNAs) in brown adipose tissue were measured", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[12, 18]], "entity_1_idx_in_text_with_entity_marker": [16, 22], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP", "entity_2_idx": [[275, 278]], "entity_2_idx_in_text_with_entity_marker": [288, 291], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p2", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative [E1]UCP[/E1] expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for [E2]UCP3[/E2] in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p3", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative [E1]UCP[/E1] expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in [E2]leptin[/E2]-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[155, 161]], "entity_2_idx_in_text_with_entity_marker": [168, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p0", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine [E1]UCP2[/E1] and [E2]UCP3[/E2] were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP2", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[35, 39]], "entity_2_idx_in_text_with_entity_marker": [48, 52], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p1", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, [E1]A beta[/E1] 25-35 had no effect on basal PIP2-PLC activity and cytosolic [E2]PI-PLC[/E2] and PIP2-PLC", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A beta", "entity_1_idx": [[10, 16]], "entity_1_idx_in_text_with_entity_marker": [14, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PI-PLC", "entity_2_idx": [[78, 84]], "entity_2_idx_in_text_with_entity_marker": [91, 97], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s328_IEPA.d138.s328.p0", "text": "In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC", "text_with_entity_marker": "In addition, [E1]glycosyl-phosphatidylinositol-specific phospholipase C[/E1] (GPI-PLC), which in isolated rat adipocytes is activated by [E2]insulin[/E2], was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "glycosyl-phosphatidylinositol-specific phospholipase C", "entity_1_idx": [[13, 67]], "entity_1_idx_in_text_with_entity_marker": [17, 71], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[128, 135]], "entity_2_idx_in_text_with_entity_marker": [141, 148], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s328_IEPA.d138.s328.p4", "text": "In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC", "text_with_entity_marker": "In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by [E1]insulin[/E1], was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the [E2]GPI-PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[128, 135]], "entity_1_idx_in_text_with_entity_marker": [132, 139], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GPI-PLC", "entity_2_idx": [[363, 370]], "entity_2_idx_in_text_with_entity_marker": [376, 383], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d142.s341_IEPA.d142.s341.p0", "text": "METHODS: We have therefore studied possible associations of the Gln27Glu and the Gly16Arg polymorphisms in the beta2AR with BMI, plasma leptin and UCP-1 mRNA expression in the intraperitoneal adipose tissue in a population of Caucasian women", "text_with_entity_marker": "METHODS: We have therefore studied possible associations of the Gln27Glu and the Gly16Arg polymorphisms in the beta2AR with BMI, plasma [E1]leptin[/E1] and [E2]UCP-1[/E2] mRNA expression in the intraperitoneal adipose tissue in a population of Caucasian women", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[136, 142]], "entity_1_idx_in_text_with_entity_marker": [140, 146], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-1", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d145.s346_IEPA.d145.s346.p0", "text": "Aggregated beta amyloid peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic phospholipase C in brain cortex", "text_with_entity_marker": "Aggregated beta [E1]amyloid[/E1] peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic [E2]phospholipase C[/E2] in brain cortex", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "amyloid", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[156, 171]], "entity_2_idx_in_text_with_entity_marker": [169, 184], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d148.s361_IEPA.d148.s361.p0", "text": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "text_with_entity_marker": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain [E1]ucp[/E1] genes and the [E2]leptin[/E2] gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ucp", "entity_1_idx": [[90, 93]], "entity_1_idx_in_text_with_entity_marker": [94, 97], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[108, 114]], "entity_2_idx_in_text_with_entity_marker": [121, 127], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d148.s361_IEPA.d148.s361.p1", "text": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "text_with_entity_marker": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain [E1]ucp[/E1] genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the [E2]leptin[/E2] gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ucp", "entity_1_idx": [[90, 93]], "entity_1_idx_in_text_with_entity_marker": [94, 97], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[183, 189]], "entity_2_idx_in_text_with_entity_marker": [196, 202], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d148.s361_IEPA.d148.s361.p3", "text": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "text_with_entity_marker": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the [E1]leptin[/E1] gene can be achieved, and suggest that adrenergic regulation of the [E2]leptin[/E2] gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[108, 114]], "entity_1_idx_in_text_with_entity_marker": [112, 118], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[183, 189]], "entity_2_idx_in_text_with_entity_marker": [196, 202], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d148.s361_IEPA.d148.s361.p5", "text": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the leptin gene and of genes of the ucp family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "text_with_entity_marker": "CONCLUSION: The results reveal that simultaneous stimulation of the expression of certain ucp genes and the leptin gene can be achieved, and suggest that adrenergic regulation of the [E1]leptin[/E1] gene and of genes of the [E2]ucp[/E2] family in adipose tissues is the result of complex interactions between the different beta-AR pathways", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[183, 189]], "entity_1_idx_in_text_with_entity_marker": [187, 193], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "ucp", "entity_2_idx": [[215, 218]], "entity_2_idx_in_text_with_entity_marker": [228, 231], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d151.s367_IEPA.d151.s367.p0", "text": "CONCLUSIONS: Our results suggest that the differences is plasma leptin, NPY, and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher NPY levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved", "text_with_entity_marker": "CONCLUSIONS: Our results suggest that the differences is plasma [E1]leptin[/E1], [E2]NPY[/E2], and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher NPY levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[64, 70]], "entity_1_idx_in_text_with_entity_marker": [68, 74], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[72, 75]], "entity_2_idx_in_text_with_entity_marker": [85, 88], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d158.s377_IEPA.d158.s377.p0", "text": "NPY-leptin: opposing effects on appetitive and consummatory ingestive behavior and sexual behavior", "text_with_entity_marker": "[E1]NPY[/E1]-[E2]leptin[/E2]: opposing effects on appetitive and consummatory ingestive behavior and sexual behavior", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[4, 10]], "entity_2_idx_in_text_with_entity_marker": [17, 23], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d159.s384_IEPA.d159.s384.p1", "text": "In conclusion, 1) UCP-2 messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma leptin levels; and 2) UCP-2 expression is not acutely regulated by food intake, insulin, or fatty acids", "text_with_entity_marker": "In conclusion, 1) [E1]UCP-2[/E1] messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma leptin levels; and 2) [E2]UCP-2[/E2] expression is not acutely regulated by food intake, insulin, or fatty acids", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UCP-2", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[180, 185]], "entity_2_idx_in_text_with_entity_marker": [193, 198], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d161.s387_IEPA.d161.s387.p0", "text": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, leptin, uncoupling protein (UCP)-2 and UCP-3, and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "text_with_entity_marker": "Using reverse transcriptase-polymerase chain reaction analysis, the mRNA expression of fatty acid translocase (FAT)/CD36, PPAR-gamma2, [E1]leptin[/E1], [E2]uncoupling protein (UCP)-2[/E2] and UCP-3, and tumor necrosis factor (TNF)-alpha was investigated in gluteal subcutaneous fat biopsies before and after 5 h infusions of saline or Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, which does not modify insulinemia", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[135, 141]], "entity_1_idx_in_text_with_entity_marker": [139, 145], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein (UCP)-2", "entity_2_idx": [[143, 169]], "entity_2_idx_in_text_with_entity_marker": [156, 182], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s408_IEPA.d168.s408.p1", "text": "These results suggest that central leptin stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of leptin on muscle UCP-3 expression", "text_with_entity_marker": "These results suggest that central [E1]leptin[/E1] stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of leptin on muscle [E2]UCP-3[/E2] expression", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[35, 41]], "entity_1_idx_in_text_with_entity_marker": [39, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[191, 196]], "entity_2_idx_in_text_with_entity_marker": [204, 209], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d170.s410_IEPA.d170.s410.p0", "text": "Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels", "text_with_entity_marker": "Influence of obesity and menopausal status on serum [E1]leptin[/E1], cholecystokinin, galanin and [E2]neuropeptide Y[/E2] levels", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[52, 58]], "entity_1_idx_in_text_with_entity_marker": [56, 62], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[89, 103]], "entity_2_idx_in_text_with_entity_marker": [102, 116], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d170.s414_IEPA.d170.s414.p0", "text": "Significantly increased leptin and galanin levels in postmenopausal obese women coupled with decreased NPY levels revealed some changes in the neuropeptides regulating eating behavior, which may be the reason for the onset of postmenopausal obesity", "text_with_entity_marker": "Significantly increased [E1]leptin[/E1] and galanin levels in postmenopausal obese women coupled with decreased [E2]NPY[/E2] levels revealed some changes in the neuropeptides regulating eating behavior, which may be the reason for the onset of postmenopausal obesity", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[24, 30]], "entity_1_idx_in_text_with_entity_marker": [28, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[103, 106]], "entity_2_idx_in_text_with_entity_marker": [116, 119], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d174.s422_IEPA.d174.s422.p1", "text": "Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration", "text_with_entity_marker": "Dietary intakes of [E1]flavonols[/E1], flavones and [E2]isoflavones[/E2] by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "flavonols", "entity_1_idx": [[19, 28]], "entity_1_idx_in_text_with_entity_marker": [23, 32], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "isoflavones", "entity_2_idx": [[43, 54]], "entity_2_idx_in_text_with_entity_marker": [56, 67], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d174.s422_IEPA.d174.s422.p4", "text": "Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration", "text_with_entity_marker": "Dietary intakes of flavonols, [E1]flavones[/E1] and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL [E2]cholesterol[/E2] concentration", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "flavones", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "cholesterol", "entity_2_idx": [[141, 152]], "entity_2_idx_in_text_with_entity_marker": [154, 165], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d177.s427_IEPA.d177.s427.p1", "text": "Interestingly, coinfusion of this regimen of NPY with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum leptin concentrations and hypothalamic NPY gene expression", "text_with_entity_marker": "Interestingly, coinfusion of this regimen of [E1]NPY[/E1] with the highly effective anorectic and body reducing effects of CNTF (5.0 microg/day) not only prevented the CNTF-induced anorexia and weight loss, but also normalized serum leptin concentrations and hypothalamic [E2]NPY[/E2] gene expression", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NPY", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[263, 266]], "entity_2_idx_in_text_with_entity_marker": [276, 279], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d182.s436_IEPA.d182.s436.p0", "text": "The effect of leptin in adult rats appears to be exerted at hypothalamic level by regulating growth hormone releasing hormone (GHRH), somatostatin and neuropeptide Y (NPY)-producing neurones", "text_with_entity_marker": "The effect of [E1]leptin[/E1] in adult rats appears to be exerted at hypothalamic level by regulating growth hormone releasing hormone (GHRH), somatostatin and [E2]neuropeptide Y[/E2] (NPY)-producing neurones", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[14, 20]], "entity_1_idx_in_text_with_entity_marker": [18, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[151, 165]], "entity_2_idx_in_text_with_entity_marker": [164, 178], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d186.s445_IEPA.d186.s445.p0", "text": "These findings are consistent with the concept that the underexpression of the nutrient-activated PLC isozyme may account for the minimal inositol phosphate (IP) and second-phase insulin secretory response from mouse islets", "text_with_entity_marker": "These findings are consistent with the concept that the underexpression of the nutrient-activated [E1]PLC[/E1] isozyme may account for the minimal inositol phosphate (IP) and second-phase [E2]insulin[/E2] secretory response from mouse islets", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[98, 101]], "entity_1_idx_in_text_with_entity_marker": [102, 105], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[179, 186]], "entity_2_idx_in_text_with_entity_marker": [192, 199], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d190.s457_IEPA.d190.s457.p0", "text": "The increase in GnRH pulse amplitude caused by leptin was totally prevented by coincubation with an anti-CART antiserum whereas it was not affected by coincubation with the NPY Y5-receptor antagonist (10(-7) M).", "text_with_entity_marker": "The increase in GnRH pulse amplitude caused by [E1]leptin[/E1] was totally prevented by coincubation with an anti-CART antiserum whereas it was not affected by coincubation with the [E2]NPY[/E2] Y5-receptor antagonist (10(-7) M).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[47, 53]], "entity_1_idx_in_text_with_entity_marker": [51, 57], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[173, 176]], "entity_2_idx_in_text_with_entity_marker": [186, 189], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d196.s477_IEPA.d196.s477.p0", "text": "When leptin signaling is defective, through a defect in either the receptor (Zucker fa/fa rat, cp/cp rat, and db/db mouse) or in the peptide itself (ob/ob mouse), the NPY system is upregulated as shown by mRNA overexpression and increased peptide release, whereas the content and/or release of some inhibitory peptides (neurotensin, cholecystokinin) are diminished.", "text_with_entity_marker": "When [E1]leptin[/E1] signaling is defective, through a defect in either the receptor (Zucker fa/fa rat, cp/cp rat, and db/db mouse) or in the peptide itself (ob/ob mouse), the [E2]NPY[/E2] system is upregulated as shown by mRNA overexpression and increased peptide release, whereas the content and/or release of some inhibitory peptides (neurotensin, cholecystokinin) are diminished.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "leptin", "entity_1_idx": [[5, 11]], "entity_1_idx_in_text_with_entity_marker": [9, 15], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[167, 170]], "entity_2_idx_in_text_with_entity_marker": [180, 183], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d197.s482_IEPA.d197.s482.p2", "text": "These results disclose the potential of the PrP to modulate the activity of CK2, a pleiotropic protein kinase that is particularly abundant in the brain", "text_with_entity_marker": "These results disclose the potential of the PrP to modulate the activity of [E1]CK2[/E1], a pleiotropic [E2]protein kinase[/E2] that is particularly abundant in the brain", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CK2", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase", "entity_2_idx": [[95, 109]], "entity_2_idx_in_text_with_entity_marker": [108, 122], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d198.s483_IEPA.d198.s483.p0", "text": "Arcuate nucleus NPY mRNA increased in rats given protein-free diet, correlating with leptin rather than decreased feeding", "text_with_entity_marker": "Arcuate nucleus [E1]NPY[/E1] mRNA increased in rats given protein-free diet, correlating with [E2]leptin[/E2] rather than decreased feeding", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NPY", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[85, 91]], "entity_2_idx_in_text_with_entity_marker": [98, 104], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d199.s485_IEPA.d199.s485.p2", "text": "Our results indicate that glucose represses gibberellin signalling late along this hormone transduction pathway, downstream of transcription of the gibberellin-modulated transcriptional activator (GAMYB) needed for alpha-amylase induction", "text_with_entity_marker": "Our results indicate that glucose represses gibberellin signalling late along this hormone transduction pathway, downstream of transcription of the [E1]gibberellin[/E1]-modulated transcriptional activator (GAMYB) needed for [E2]alpha-amylase[/E2] induction", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gibberellin", "entity_1_idx": [[148, 159]], "entity_1_idx_in_text_with_entity_marker": [152, 163], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[215, 228]], "entity_2_idx_in_text_with_entity_marker": [228, 241], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
